Related Experiment Video

Updated: Jan 31, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

15.5K

Hemodynamic monitoring using thoracic bioimpedance - an optimal solution for the treatment of hypertension

Anca Daniela Farcas1, Florin Petru Anton1, Mihaela Mocan1

  • 1Internal Medicine Department, Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca, Romania. Internal Medicine Department, Emergency County Clinical Hospital Cluj-Napoca, Romania.

Clujul Medical (1957)
|December 20, 2018
PubMed

Insights

Hypertension management can be improved by viewing it as a hemodynamic disorder. Tailored therapy using hemodynamic monitoring, like the HOTMAN system, achieved blood pressure control in a complex patient case.

Area of Science:

  • Cardiology
  • Medical Technology
  • Hypertension Research

Background:

  • Hypertension is a significant public health concern with high prevalence and severe complications.
  • Ineffective blood pressure control contributes to adverse health outcomes.
  • Individualized hemodynamic assessment is crucial for effective hypertension management.

Observation:

  • A 59-year-old male with diabetes, dyslipidemia, and obesity presented with uncontrolled hypertension despite treatment with five antihypertensive drug classes.
  • The patient developed left ventricular failure due to persistent high blood pressure.
  • The HOTMAN system, utilizing thoracic electrical bioimpedance, was employed for hemodynamic monitoring.

Findings:

  • The HOTMAN system facilitated rapid identification of the underlying hemodynamic imbalance.
  • Therapy guided by hemodynamic parameters led to successful blood pressure control within five days.
  • This case demonstrates the efficacy of a tailored, hemodynamically-guided treatment approach.

Implications:

  • Viewing hypertension as a hemodynamic disorder enables personalized treatment strategies.
  • Hemodynamic monitoring can significantly shorten treatment initiation and stabilization periods.
  • This approach holds potential for improving hypertension control rates and reducing complications.

Keywords:
antihypertensive treatmentbio-impedancehemodynamichypertensiontreatment

More Related Videos

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS08:12

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS

Published on: November 26, 2018

10.6K
Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension09:40

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension

Published on: April 11, 2016

21.7K

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
601
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
467
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
508
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
619
Thoracic Aorta01:15

Thoracic Aorta

The thoracic section of the aorta begins at the T5 vertebra and extends to the T12 level at the diaphragm, initially progressing through the mediastinum to the left of the spinal column. Throughout its course in the thoracic segment, the thoracic aorta emits various offshoots known collectively as visceral and parietal branches. The branches that predominantly supply blood to visceral organs are termed visceral branches and include bronchial, pericardial, esophageal, and mediastinal arteries,...
1.7K
The Thoracic Cage: Sternum01:17

The Thoracic Cage: Sternum

The thoracic or rib cage forms the body's thorax (chest) portion. Its primary function in the body is to protect vital organs in the thoracic cavity, such as the heart and the lungs. It consists of 12 pairs of ribs with their costal cartilages and the sternum. The ribs are anchored posteriorly to the 12 thoracic vertebrae (T1-T12).
The sternum is the elongated bony structure on the anterior side of the thoracic cage. It consists of three parts: the manubrium, the body, and the xiphoid...
6.0K